Skip to main content

Table 6 Results of this analysis

From: Comparing Stent Thrombosis associated with Zotarolimus Eluting Stents versus Everolimus Eluting Stents at 1 year follow up: a systematic review and meta-analysis of 6 randomized controlled trials

Outcomes analyzed

No of trials reporting these outcomes (n)

OR with 95% CI

P value

I2 (%)

Any definite ST

6

1.70 [0.92 – 3.16]

0.09

43

Acute definite ST

4

3.44 [0.82 – 14.43]

0.09

0

Subacute definite ST

4

1.13 [0.43 – 2.95]

0.80

46

Late definite ST

4

2.39 [0.83 – 6.85]

0.11

0

Any probable ST

6

1.11 [0.60 – 2.05]

0.75

20

Acute probable ST

3

0.53 [0.12 – 2.40]

0.41

0

Subacute probable ST

3

0.98 [0.14 – 6.63]

0.98

67

Late probable ST

3

1.67 [0.35 – 7.86]

0.52

0

Any definite or probable ST

6

1.39 [0.89 – 2.17]

0.15

7

Possible ST

4

1.08 [0.64 – 1.82]

0.78

0

Definite/probable or possible ST

3

1.19 [0.84 – 1.70]

0.33

0

  1. Abbreviations: OR odds ratios, CI confidence intervals, ST stent thrombosis